Llwytho...

Design, Synthesis and Evaluation of Anti-CD38 Antibody Drug Conjugate Based on Daratumumab and Maytansinoid

Daratumumab, an FDA approved antibody drug, displays specific targeting ability to abnormal white blood cells overexpressing CD38 and provides efficacious therapy for multiple myeloma. Here, in order to achieve enhanced remission of multiple myeloma, we designed Dara-DM4, antibody drug conjugates (A...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Bioorg Med Chem
Prif Awduron: Zhang, Xinfu, Zhang, Chengxiang, Yang, Xiaomei, Hou, Xucheng, Zhao, Weiyu, Benson, Don, Yu, Jianhua, Dong, Yizhou
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2018
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6339845/
https://ncbi.nlm.nih.gov/pubmed/30594452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2018.12.024
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!